[1] |
石岩,刘大为. 降钙素原在全身性感染诊治中的研究进展[J]. 中华内科杂志,2011,50(5):444-446.
|
[2] |
MARSHALL JC,REINHART K,International Sepsis Forum.Biomarkers of sepsis[J]. Crit Care Med,2009,37(7):2290-2298.
|
[3] |
SIMON L,GAUVIN F,AMRE DK,et al.Serum procalcitonin and C-reactive protein levels as markers of bacterial infection:a systematic review and meta-analysis[J]. Clin Infect Dis,2004,39(2):206-217.
|
[4] |
BOUADMA L,LUYT CE,TUBACH F,et al.Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial):a multicentre randomised controlled trial[J]. Lancet,2010,375(9713):463-474.
|
[5] |
TANG BM,ESLICK GD,GRAIG JC,et al.Accuracy of procalcitonin for sepsis diagnosis in critically ill patients:systematic review and meta-analysis[J]. Lancet Infect Dis,2007,7(3):210-217.
|
[6] |
CHRIST-GRAIN M, MLLER B.Procalcitonin in bacterial infections-hype,hope,more or less?[J]. Swiss Med Wkly,2005,135(5):451-460.
|
[7] |
李茉莉,潘频华,胡成平. 呼吸ICU医院获得性肺炎的病原学分布与致病菌耐药性的变迁[J]. 中南大学学报(医学版),2013,38(3):251-257.
|
[8] |
中华医学会呼吸病学分会. 医院获得性肺炎诊断和治疗指南(草案)[J]. 中华结核和呼吸杂志,1999,22(4):201-203.
|
[9] |
叶应妩,王毓三,申子瑜. 全国临床检验操作规程[M]. 3版. 南京:东南大学出版社,2006:133.
|
[10] |
石岩,徐英春,芮曦,等. 降钙素原变化率在重症细菌性肺炎疗效评估中的作用[J]. 中华检验医学杂志,2013,36(7):615-619.
|
[11] |
刘桂香,商润萍,武燕敏. 降钙素原在重症监护室肺部感染早期诊断中的应用[J]. 检验医学,2015,30(2):203-205.
|
[12] |
RAMIREZ P,GARCIA MA,FERRER M,et al.Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia[J]. Eur Respir J,2008,31(2):356-362.
|
[13] |
慕月晶,王伟佳,徐胜男,等. 动态监测血清降钙素原水平对感染再发的诊断价值[J]. 检验医学,2015,30(9):881-885.
|
[14] |
MEHANIC S,BALJIC R.The importance of serum procalcitonin in diagnosis and treatment of serious bacterial infections and sepsis[J]. Mater Sociomed,2013,25(4):277-281.
|
[15] |
陈振华,谭笑,余艳艳,等. 血清降钙素原在肺结核合并肺部感染诊断中的应用[J]. 中国感染控制杂志,2014,13(8):482-485.
|
[16] |
陈飞. C-反应蛋白联合降钙素原检测鉴别肺部感染病原体的临床价值[J]. 中国医学创新,2012,9(12):91-92.
|
[17] |
戴佩佩,裘晓乐,徐克. 降钙素原与C反应蛋白联合检测在细菌感染中的应用[J]. 检验医学,2010,25(11):858-860.
|